2023
DOI: 10.1002/14651858.cd007986.pub3
|View full text |Cite
|
Sign up to set email alerts
|

Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
13
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(14 citation statements)
references
References 128 publications
1
13
0
Order By: Relevance
“…In addition, this supplementation resulted in a noticeable clinical improvement ( 44 ). A recent meta-analysis showed that polyunsaturated fatty acids (PUFA) may have a limited effect on treatment outcomes in ADHD ( 45 ). Nevertheless, a better understanding of the inflammatory background in ADHD may help to identify patients with higher levels of inflammation.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, this supplementation resulted in a noticeable clinical improvement ( 44 ). A recent meta-analysis showed that polyunsaturated fatty acids (PUFA) may have a limited effect on treatment outcomes in ADHD ( 45 ). Nevertheless, a better understanding of the inflammatory background in ADHD may help to identify patients with higher levels of inflammation.…”
Section: Discussionmentioning
confidence: 99%
“…In the past decade, a number of systematic reviews and meta-analyses have examined the potential of ω-6 and ω-3 PUFAs as supplementary treatments for ADHD (Puri and Martins, 2014;Derbyshire, 2017;Gillies et al, 2023). Additionally, blood long chain-PUFAs levels in erythrocyte membranes and plasma are lower in children with ADHD compared to healthy control groups, according to the previous studies (Stevens et al, 1995;Burgess et al, 2000;Antalis et al, 2006).…”
Section: Polyunsaturated Fatty Acids (Pufas)mentioning
confidence: 98%
“…An upsurge in trials is indicated by the 24 additional RCTs included in this update of the original 2012 review. 14 Despite the expanded evidence base, Gillies et al 1 found there is low-certainty evidence to support the efficacy of PUFA supplementation in alleviating ADHD symptoms compared to placebo, but high-certainty evidence that PUFA supplementation does not improve core ADHD symptoms. This suggests PUFA supplements should not be recommended as a stand-alone, routine treatment for ADHD.…”
Section: How Did the Authors Conclude On The Evidence?mentioning
confidence: 99%
“…3 ADHD frequently persists into adulthood and is associated with educational, occupational, behavioral, and social challenges. 1,3 Genetic, neurobiological, psychosocial, and environmental factors likely contribute to ADHD, with genetics playing the predominant role, accounting for approximately 75% of its etiology. 4 Primary treatment options include non-pharmacological approaches such as behavioral therapy.…”
mentioning
confidence: 99%
See 1 more Smart Citation